314 related articles for article (PubMed ID: 1650217)
1. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties.
van Zyl JM; Basson K; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1991 Jul; 42(3):599-608. PubMed ID: 1650217
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs.
Kettle AJ; Winterbourn CC
Biochem Pharmacol; 1991 May; 41(10):1485-92. PubMed ID: 1850278
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the myeloperoxidase-H2O2-Cl- system of neutrophils by indomethacin and other non-steroidal anti-inflammatory drugs.
Shacter E; Lopez RL; Pati S
Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):975-84. PubMed ID: 1848981
[TBL] [Abstract][Full Text] [Related]
4. Interaction of methyl-xanthines with myeloperoxidase. An anti-inflammatory mechanism.
van Zyl JM; Kriegler A; van der Walt BJ
Int J Biochem; 1992 Jun; 24(6):929-35. PubMed ID: 1319356
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.
Pekoe G; Van Dyke K; Mengoli H; Peden D; English D
Agents Actions; 1982 Apr; 12(1-2):232-8. PubMed ID: 6282074
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peroxidase-catalyzed reactions by deferoxamine.
Klebanoff SJ; Waltersdorph AM
Arch Biochem Biophys; 1988 Aug; 264(2):600-6. PubMed ID: 2840860
[TBL] [Abstract][Full Text] [Related]
7. Activation of chlorpromazine by the myeloperoxidase system of the human neutrophil.
van Zyl JM; Basson K; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1990 Sep; 40(5):947-54. PubMed ID: 2167682
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
[TBL] [Abstract][Full Text] [Related]
9. Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase.
Kettle AJ; Gedye CA; Winterbourn CC
Biochem Pharmacol; 1993 May; 45(10):2003-10. PubMed ID: 8390258
[TBL] [Abstract][Full Text] [Related]
10. Anti-oxidant properties of H2-receptor antagonists. Effects on myeloperoxidase-catalysed reactions and hydroxyl radical generation in a ferrous-hydrogen peroxide system.
van Zyl JM; Kriegler A; van der Walt BJ
Biochem Pharmacol; 1993 Jun; 45(12):2389-97. PubMed ID: 8101078
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone.
Bozeman PM; Learn DB; Thomas EL
Biochem Pharmacol; 1992 Aug; 44(3):553-63. PubMed ID: 1324677
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of reaction of myeloperoxidase with hydrogen peroxide and chloride ion.
Furtmüller PG; Obinger C; Hsuanyu Y; Dunford HB
Eur J Biochem; 2000 Oct; 267(19):5858-64. PubMed ID: 10998045
[TBL] [Abstract][Full Text] [Related]
13. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase.
Vlasova II; Sokolov AV; Arnhold J
J Inorg Biochem; 2012 Jan; 106(1):76-83. PubMed ID: 22112843
[TBL] [Abstract][Full Text] [Related]
14. Human hemi-myeloperoxidase. Initial chlorinating activity at neutral pH, compound II and III formation, and stability towards hypochlorous acid and high temperature.
Zuurbier KW; van den Berg JD; Van Gelder BF; Muijsers AO
Eur J Biochem; 1992 Apr; 205(2):737-42. PubMed ID: 1315274
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase acts as a source of free iron during steady-state catalysis by a feedback inhibitory pathway.
Maitra D; Shaeib F; Abdulhamid I; Abdulridha RM; Saed GM; Diamond MP; Pennathur S; Abu-Soud HM
Free Radic Biol Med; 2013 Oct; 63():90-8. PubMed ID: 23624305
[TBL] [Abstract][Full Text] [Related]
16. Secretion and inactivation of myeloperoxidase by isolated neutrophils.
King CC; Jefferson MM; Thomas EL
J Leukoc Biol; 1997 Mar; 61(3):293-302. PubMed ID: 9060452
[TBL] [Abstract][Full Text] [Related]
17. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols.
Hazen SL; Hsu FF; Duffin K; Heinecke JW
J Biol Chem; 1996 Sep; 271(38):23080-8. PubMed ID: 8798498
[TBL] [Abstract][Full Text] [Related]
18. Formation of spiroiminodihydantoin nucleoside by reaction of 8-oxo-7,8-dihydro-2'-deoxyguanosine with hypochlorous acid or a myeloperoxidase-H(2)O(2)-Cl(-) system.
Suzuki T; Masuda M; Friesen MD; Ohshima H
Chem Res Toxicol; 2001 Sep; 14(9):1163-9. PubMed ID: 11559029
[TBL] [Abstract][Full Text] [Related]
19. Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.
Shaeib F; Khan SN; Ali I; Najafi T; Maitra D; Abdulhamid I; Saed GM; Pennathur S; Abu-Soud HM
PLoS One; 2015; 10(3):e0120737. PubMed ID: 25835505
[TBL] [Abstract][Full Text] [Related]
20. Thyroxine-supported oxidation in the myeloperoxidase system.
van Zyl JM; van der Walt BJ; Kriegler A
Horm Metab Res; 1993 Nov; 25(11):569-72. PubMed ID: 8288159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
